12:00 AM
Jun 08, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Darinaparsin: Phase II data

Data from 19 evaluable patients who have undergone prior therapy in an ongoing, open-label Phase II trial, showed that IV darinaparsin resulted in 3 complete responses, 4 partial responses and 4 cases of...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >